Request for Proposals:

RFP 1.0 - Production
RFP 2.0 - Purification
RFP 3.0 - Formulation
RFP 4.0 - Vialing and Freezing
RFP 5.0 - Repository Services
RFP 6.0 - Plasmid Production  
RFP 7.0 - Plastic Ware Donation
RFP 8.0 - Medium Donation

Awarded Bids:

RFP 1.0 - Production
RFP 1.0 - Production Addendum
RFP 4.0 - Vialing and Freezing
RFP 5.0 - Repository Services
RFP 7.0 - Plastic Ware and RFP 8.0 - Medium Donation
RFP 8.0 - Medium Donation

Meeting Minutes:

WG Meeting on 6/5/2003
WG Meeting on 6/3/2004
Attendee List - WG Meeting 6/3/2004

Presentations:

Overview
Manufacturing
Characterization
ASGT Presentation by Richard Snyder
Articles:
AAV Reference Standard
Container Stability Study:

This is an on-going study to look at the short-term stability (1 hour, 1 day, 3 days, 7 days) of the vector at room-temperature (the temperature for the vial filling) and long-term -80oC storage temperature (1 hour, 1 day, 14 days, 35 days, 124 days–still to be tested in October) in these containers. We have a bid proposal from Introgen Therapeutics to fill the Reference Standard in glass vials, so we conducted this comparative study since we only had stability data in polypropylene cryovials.

The vector was dispensed into both glass vials and cryovials, and stored: A) frozen; and B) room temp for the indicated time. The infectious titer (green cells) was tested at each timepoint in triplicate. (48) vials (cryo and glass) were filled with 0.5ml at 2X10e11vg/ml each (= 24ml @ 2X10e11vg/ml = 4.8x10e12vg total used), as specified for the Reference Standard.

Please see the attached stability data for the AAV2-GFP vector filled into cryovials (standard container for UF) and glass vials.

Plastic vs Glass Stability
Production Schedule:

All donated reagents and materials were received, and production and purification of the reference standard started in March 2006 at the University of Florida’s Powell Gene Therapy Center Vector Core. Approximately 150ml of AAV2-GFP = 5.69X10e14vg (= 3.79X10e12vg/ml) was made.

The Reference Standard was diluted to the proper concentration (2X10e11vg/ml), filtered and divided into 2 portions. In March 2008, ATCC filled 0.5ml into each vial for a total of 2,087 vials, and the vials have been frozen and transferred to the repository at ATCC. Characterization of the Reference Standard by member laboratories will begin in Q2 of 2008, followed by statistical analysis, with availability expected in Q3, 2008.

Protocols and Test Records for AAV Reference Standards:

AAV2 Working Group Member List Updated 04/10/08
For more information, please contact the
Chair of the AAV Reference Standard Working Group:
Richard O. Snyder, PhD
PO Box 110585, University of Florida, Gainesville, FL 32611-0585
Phone: 386-418-1642 • Fax: 386-462-7365Email: rsnyder@cerhb.ufl.edu


P.O. Box 1229, Virginia Beach, VA 23451-0229
Phone: (757) 423-8823  Fax: (757) 423-2065  E-mail: referencematerial@wilbio.com